Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 7: 42317, 2017 02 07.
Article in English | MEDLINE | ID: mdl-28169367

ABSTRACT

Epidemiological studies have shown that air pollution is associated with the morbidity and mortality from cardiopulmonary diseases. Currently, limited experimental models are available to evaluate the physiological and cellular pathways activated by chronic multi-pollutant exposures. This manuscript describes an atmospheric simulation reactor (ASR) that was developed to investigate the health effects of air pollutants by permitting controlled chronic in vivo exposure of mice to combined particulate and gaseous pollutants. BALB/c mice were exposed for 1 hr/day for 3 consecutive days to secondary organic aerosol (SOA, a common particulate air pollutant) at 10-150 µg/m3, SOA (30 µg/m3) + ozone (65 ppb) or SOA + ozone (65 ppb) + nitrogen dioxide (NO2; 100 ppb). Daily exposure to SOA alone led to increased airway hyperresponsiveness (AHR) to methacholine with increasing SOA concentrations. Multi-pollutant exposure with ozone and/or NO2 in conjunction with a sub-toxic concentration of SOA resulted in additive effects on AHR to methacholine. Inflammatory cell recruitment to the airways was not observed in any of the exposure conditions. The ASR developed in this study allows us to evaluate the chronic health effects of relevant multi-pollutant exposures at 'real-life' levels under controlled conditions and permits repeated-exposure studies.


Subject(s)
Atmosphere/chemistry , Environmental Monitoring/instrumentation , Particulate Matter/adverse effects , Aerosols , Air Pollutants/adverse effects , Animals , Female , Gas Chromatography-Mass Spectrometry , Inflammation/pathology , Lung/pathology , Methacholine Chloride/pharmacology , Mice, Inbred BALB C , Nitrogen Dioxide , Ozone , Particulate Matter/chemistry , Respiration/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...